Mr. Speaker, we all understand the situation very well. We have been listening to committees as to exactly what they have been doing. We understand that there are certain ways that cloned funds and derivatives have been used in various ways. This is a reality of the marketplace. There is nothing new here at all. This is a matter which the government has under active review.
In the House of Commons on December 15th, 1999. See this statement in context.